BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
Year: 2011
Type: article
Source: Blood
Institutions: University of Bologna, Jena University Hospital, Hôpital Edouard Herriot, UiT The Arctic University of Norway, University Hospital Leipzig, University of Turin, Federico II University Hospital, CEINGE Biotecnologie Avanzate Franco Salvatore (Italy), University of Naples Federico II, Heidelberg University, Medizinische Fakultät Mannheim, University of Helsinki, Helsinki University Hospital, Salisbury District Hospital, Wessex Regional Genetics Laboratory, University of Southampton
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: European Commission
OpenAlex ID: W2016809033